Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Health Care

63.27
+0.01250.02%
Post-market: 63.270.00000.00%19:30 EDT
Volume:17.10K
Turnover:1.08M
Market Cap:96.80M
PE:- -
High:63.50
Open:63.50
Low:62.25
Close:63.26
52wk High:64.60
52wk Low:39.32
Shares:1.53M
Float Shares:1.53M
Volume Ratio:1.31
T/O Rate:1.12%
Dividend:0.71
Dividend Rate:1.12%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?

Simply Wall St.
·
Aug 12

Apogee Shareholders Approve AbbVie Acquisition and Leadership Transition

TIPRANKS
·
Aug 12

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung

Reuters
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial

TIPRANKS
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

Abbvie : BNP Paribas Raises Target Price to $247 from $218

THOMSON REUTERS
·
Aug 11

Merck Price Target Raised to $145.00/Share from $130.00 by Argus Research

Dow Jones
·
Aug 11

Argus Adjusts Price Target on Merck & Co. to $145 From $130, Keeps Buy Rating

MT Newswires Live
·
Aug 11

Merck price target raised to $145 from $130 at Argus

TIPRANKS
·
Aug 11

Merck & Co Inc : Argus Research Raises Target Price to $145 from $130

THOMSON REUTERS
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

MSD R&D China Signs Cooperation Agreement with InventisBio

Reuters
·
Aug 11

Msd R&D China Says it Signed Cooperation Agreement with Inventisbio to Advance Clinical Development of Small Molecule Oncology Drugs - Company Statement

THOMSON REUTERS
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11